Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-10 Sale |
2024-12-12 4:39 pm |
Scholar Rock Holding Corp | SRRK | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner |
1,600,000 | $41.65 | $66,640,000 | 9,250,005 (Direct) |
View |
| 2024-11-25 Sale |
2024-11-27 4:31 pm |
Scholar Rock Holding Corp | SRRK | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner |
409,433 | $38.49 | $15,757,639 | 10,850,005 (Direct) |
View |
| 2024-08-07 Sale |
2024-08-09 4:30 pm |
GLYCOMIMETICS INC | GLYC | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner |
322,361 | $0.18987 | $61,206 | 6,317,565 (Direct) |
View |
| 2024-08-05 Sale |
2024-08-07 4:30 pm |
GLYCOMIMETICS INC | GLYC | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner |
220,255 | $0.18698 | $41,184 | 6,639,926 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:53 pm |
GLYCOMIMETICS INC | GLYC | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner |
349,764 | $0.20327 | $71,097 | 6,860,181 (Direct) |
View |
| 2024-07-26 Sale |
2024-07-30 5:16 pm |
GLYCOMIMETICS INC | GLYC | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner |
1,379,119 | $0.2286 | $315,262 | 7,209,945 (Direct) |
View |
| 2023-10-10 Purchase |
2023-10-12 4:01 pm |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
1,000,000 | $1.104 | $1,103,957 | 6,792,051 (Indirect Direct) |
View |
| 2022-11-10 Purchase |
2022-11-15 5:26 pm |
WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director |
75,000 | $4.2674 | $320,055 | 126,432 (Direct) |
View |
| 2022-08-05 Purchase |
2022-08-09 4:48 pm |
LEXICON PHARMACEUTICALS INC. | LXRX | Invus US Partners LLC Ulys L.L.C. DEBBANE RAYMOND Director 10% Owner |
147,390 | $2.5 | $368,475 | 5,782,749 (Indirect Direct) |
View |
| 2022-08-01 Purchase |
2022-08-01 4:15 pm |
LEXICON PHARMACEUTICALS INC. | LXRX | Invus US Partners LLC Ulys L.L.C. DEBBANE RAYMOND Director 10% Owner |
982,600 | $2.5 | $2,456,500 | 5,635,359 (Indirect Direct) |
View |
| 2022-08-01 Purchase |
2022-08-01 4:13 pm |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
982,600 | $2.5 | $2,456,500 | 5,635,359 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2024-07-29 6:03 pm |
N/A N/A |
Scholar Rock Holding Corp | SRRK | Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner |
0 | $0 | 12,834,446 (Direct) |
View |
Ownership |
2024-07-29 5:55 pm |
N/A N/A |
GLYCOMIMETICS INC | GLYC | Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner |
0 | $0 | 8,589,064 (Direct) |
View |
| 2024-05-13 Option Award |
2024-05-13 4:02 pm |
N/A 2034-05-13 |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
81,716 | $0 | 81,716 (Direct) |
View |
| 2024-04-28 Exercise |
2024-04-29 4:17 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
8,032 | $0 | 6,800,083 (Direct) |
View |
| 2023-05-21 Exercise |
2023-05-22 4:03 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
9,302 | $0 | 5,792,051 (Direct) |
View |
| 2023-05-09 Option Award |
2023-05-11 4:12 pm |
N/A N/A |
WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Former Director Director |
835 | $0 | 134,387 (Direct) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:22 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
20,690 | $0 | 20,690 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 4:05 pm |
N/A N/A |
WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director |
2,053 | $0 | 133,552 (Direct) |
View |
| 2023-01-02 Option Award |
2023-01-04 4:22 pm |
N/A N/A |
WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director |
5,067 | $0 | 131,499 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-05 5:27 pm |
N/A N/A |
WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director |
4,595 | $0 | 51,432 (Direct) |
View |
| 2022-07-04 Option Award |
2022-07-06 4:31 pm |
N/A N/A |
WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director |
2,745 | $0 | 46,837 (Direct) |
View |
| 2022-05-21 Option Award |
2022-05-23 4:14 pm |
N/A 2032-05-21 |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
23,704 | $0 | 23,704 (Direct) |
View |
| 2022-04-30 Exercise |
2022-05-02 4:14 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
4,024 | $0 | 4,652,759 (Direct) |
View |
| 2022-04-04 Option Award |
2022-04-06 4:15 pm |
N/A N/A |
WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director |
1,797 | $0 | 44,092 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:16 pm |
N/A N/A |
WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director |
1,179 | $15.9 | 42,295 (Direct) |
View |
| 2021-10-04 Option Award |
2021-10-06 4:07 pm |
N/A N/A |
WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director |
998 | $18.78 | 41,116 (Direct) |
View |
| 2021-07-05 Option Award |
2021-07-07 4:20 pm |
N/A N/A |
WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director |
523 | $35.84 | 40,118 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-03 5:03 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
10,499 | $0 | 10,499 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:47 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
10,638 | $0 | 4,648,735 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-07 4:17 pm |
N/A N/A |
WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director |
609 | $30.77 | 39,595 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:16 pm |
N/A N/A |
WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director |
724 | $0 | 38,986 (Direct) |
View |
| 2020-09-28 Option Award |
2020-09-30 5:47 pm |
N/A N/A |
WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director |
996 | $0 | 38,262 (Direct) |
View |
| 2020-06-29 Option Award |
2020-07-01 4:09 pm |
N/A N/A |
WW INTERNATIONAL INC. | WW | DEBBANE RAYMOND Director |
740 | $0 | 37,266 (Direct) |
View |
| 2020-04-26 Exercise |
2020-04-27 4:45 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
3,466 | $0 | 4,666,850 (Direct) |
View |
| 2020-04-24 Option Award |
2020-04-27 4:45 pm |
N/A 2030-04-24 |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
28,753 | $0 | 4,666,850 (Direct) |
View |